The University of Kansas Hospital — Kansas City, Kansas

The University of Kansas Hospital is a clinical research site located in Kansas City, Kansas, United States 66160.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

The University of Kansas Hospital has participated in 28 clinical trials with 15 currently active.

Therapeutic areas: Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Adenocarcinoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer, Insight Molecular Diagnostics.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Kansas Hospital?

The University of Kansas Hospital has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Kansas Hospital conducted?

The University of Kansas Hospital has 28 clinical trials on record, with 15 currently active. Their work covers Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Adenocarcinoma.

Is The University of Kansas Hospital accredited by Crixeo Health?

Yes — The University of Kansas Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about The University of Kansas Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.